NASDAQ · PPH

VanEck Pharmaceutical ETF (PPH)

$111.48+0.12%
Close Sep 28, 2026 · split-adjusted
Sep 28, 2026$111.48▲ 27.65% in range
Sep 29, 2025Low $87.33 · High $117.87Sep 28, 2026
What changed · written from our data
As of Sep 28, 2026

VanEck Pharmaceutical ETF closed at $111.48 on Sep 28, up 0.12%, 5.4% below its 52-week closing high. Volume of 499.7K shares was 2.03× its 20-day average (well above normal).

Split-adjusted performance: -2.3% over one month, +10.4% over six months, +29.6% over one year.

Short interest was 2.5M shares at the Sep 15 settlement (11.5 days to cover).

Market cap$1.02B9.2M shares
Revenue · quarter——
Diluted EPS——
P/E · TTM—
Net margin—
Dividend yield2.24%$0.6248 last paid
52-week range85.99 – 117.87−5.4% from high
Volume499.7K2.03× 20-day avg
Volatility · 60d19.6%Annualised
Short % of float—11.5 days to cover
Net cash—
Next earnings—Not scheduled
Split-adjusted performance
1W −0.2%1M −2.3%3M +0.9%6M +10.4%YTD +8.1%1Y +29.6%3Y +37.5%5Y +53.5%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within industry

Not enough peers to rank

6-month momentum—
Revenue growth—
Net margin—
Value (low P/E)—
Size—

Short interest

Details →
Shares short2.5M−0.9% vs prior
Days to cover11.5Settled Sep 15
% of float—
Short vol. 10d58.2%of daily volume

Quick answers

What is PPH's market cap?
$1.02B, based on the Sep 28 close of $111.48.
Does VanEck Pharmaceutical ETF pay a dividend?
Yes. The latest regular dividend was $0.6248 per share (ex-date Jul 1), an annualised yield of 2.24%.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology